• Live
    • Audio Only
  • google plus
  • facebook
  • twitter
News > Bolivia

Bolivia Will Produce COVID Vaccines, Including Sputnik V

  • @ChaskiReport 1.7 million SputnikV COVID vaccines, which were supposed to arrive in Bolivia this week, have been delayed by a month supposedly due to bureaucratic problems in Russia. Sputnik V is one of the three vaccines used here.

    @ChaskiReport 1.7 million SputnikV COVID vaccines, which were supposed to arrive in Bolivia this week, have been delayed by a month supposedly due to bureaucratic problems in Russia. Sputnik V is one of the three vaccines used here. | Photo: Twitter @ChaskiReport

Published 30 April 2021
Opinion

As part of Russia's growing involvement in Latin America in the fight to battle the COVID pandemic and its effects on the region, Bolivia is looking to join Argentina in the production of Sputnik V, the Russian vaccine.

Bolivian Health Minister Health Minister Jeyson Auza says that the Andean nation is interested in producing vaccines against COVID-19, including the Russian Sputnik V, on its territory. "We would be delighted to be able, like Argentina, to produce vaccines in the not too distant future," he said.

RELATED

Bolivia To Close Borders To Prevent Entry Of COVID-19 Strains

Argentina will produce Sputnik V and AstraZeneca vaccines.

Auza stressed that negotiations with Russia on the production of the vaccine had not yet begun.

"However, there is a private business that offers us, as a state, the possibility that we, united, could very quickly receive the necessary funds that will allow the transfer of technology with Russia," he said. Bolivia mustn't create any association with "this or that private company", Auza added.


"We are interested in the possibility of establishing relations with Russia or another country in the world in the near future, which would allow us to exchange knowledge to have sovereignty in the epidemiological sphere," he concluded.

Bolivia registered the Sputnik V coronavirus vaccine based on Russia's clinical trial data in early January.

Comment
0
Comments
Post with no comments.